PVA/PMMA polymer blended composite electrospun nanofibers mat and their potential use as an anti‐biofilm product
Bacterial infections have increased dramatically due to microbial biofilm formation resulting in chronic pathological conditions in human subjects. Microbial biofilm causes poor drug penetration and antibiotic resistance, which has made site‐specific sustained drug delivery the most appropriate opti...
Saved in:
Published in | Journal of applied polymer science Vol. 138; no. 18 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
10.05.2021
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Bacterial infections have increased dramatically due to microbial biofilm formation resulting in chronic pathological conditions in human subjects. Microbial biofilm causes poor drug penetration and antibiotic resistance, which has made site‐specific sustained drug delivery the most appropriate option. Our work entails fabrication of ciprofloxacin hydrochloride (CPX) loaded nanofibers using polyvinyl alcohol (PVA) and poly(meth) methacrylate (PMMA) employing electrospinning method to form PVA:PMMA:CPX nanofibers mat. These nanofibers mat were optimized, characterized, and further subjected to anti‐biofilm activity. Microscopic images revealed average nanofibers diameter of 243 ± 80 nm with smooth surface morphology. Analytical graphs and thermal analysis confirmed drug encapsulation and drug‐polymer compatibility. In vitro studies demonstrated sustained release of CPX for 22 days displaying Hixon Crowell and two‐stage desorption kinetics. Anti‐biofilm activity showed zones of inhibition 3.0 ± 0.5 cm, 2.8 ± 0.1 cm, 2.9 ± 0.2 cm for Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, respectively which was well above the minimum inhibitory concentration levels of the bacteria forming biofilm. Conclusively, these nanofibers mat have potential to be used as an anti‐biofilm product. |
---|---|
AbstractList | Bacterial infections have increased dramatically due to microbial biofilm formation resulting in chronic pathological conditions in human subjects. Microbial biofilm causes poor drug penetration and antibiotic resistance, which has made site‐specific sustained drug delivery the most appropriate option. Our work entails fabrication of ciprofloxacin hydrochloride (CPX) loaded nanofibers using polyvinyl alcohol (PVA) and poly(meth) methacrylate (PMMA) employing electrospinning method to form PVA:PMMA:CPX nanofibers mat. These nanofibers mat were optimized, characterized, and further subjected to anti‐biofilm activity. Microscopic images revealed average nanofibers diameter of 243 ± 80 nm with smooth surface morphology. Analytical graphs and thermal analysis confirmed drug encapsulation and drug‐polymer compatibility. In vitro studies demonstrated sustained release of CPX for 22 days displaying Hixon Crowell and two‐stage desorption kinetics. Anti‐biofilm activity showed zones of inhibition 3.0 ± 0.5 cm, 2.8 ± 0.1 cm, 2.9 ± 0.2 cm for Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, respectively which was well above the minimum inhibitory concentration levels of the bacteria forming biofilm. Conclusively, these nanofibers mat have potential to be used as an anti‐biofilm product. Bacterial infections have increased dramatically due to microbial biofilm formation resulting in chronic pathological conditions in human subjects. Microbial biofilm causes poor drug penetration and antibiotic resistance, which has made site‐specific sustained drug delivery the most appropriate option. Our work entails fabrication of ciprofloxacin hydrochloride (CPX) loaded nanofibers using polyvinyl alcohol (PVA) and poly(meth) methacrylate (PMMA) employing electrospinning method to form PVA:PMMA:CPX nanofibers mat. These nanofibers mat were optimized, characterized, and further subjected to anti‐biofilm activity. Microscopic images revealed average nanofibers diameter of 243 ± 80 nm with smooth surface morphology. Analytical graphs and thermal analysis confirmed drug encapsulation and drug‐polymer compatibility. In vitro studies demonstrated sustained release of CPX for 22 days displaying Hixon Crowell and two‐stage desorption kinetics. Anti‐biofilm activity showed zones of inhibition 3.0 ± 0.5 cm, 2.8 ± 0.1 cm, 2.9 ± 0.2 cm for Escherichia coli , Staphylococcus aureus , Enterococcus faecalis , respectively which was well above the minimum inhibitory concentration levels of the bacteria forming biofilm. Conclusively, these nanofibers mat have potential to be used as an anti‐biofilm product. |
Author | Chauhan, Deepika Das, Ayan K. Iqbal, Zeenat Solanki, Pratima R. Singh, Manvi |
Author_xml | – sequence: 1 givenname: Manvi orcidid: 0000-0002-9869-8077 surname: Singh fullname: Singh, Manvi organization: School of Pharmaceutical Education and Research, Jamia Hamdard – sequence: 2 givenname: Deepika orcidid: 0000-0002-1129-6578 surname: Chauhan fullname: Chauhan, Deepika organization: Jawaharlal Nehru University – sequence: 3 givenname: Ayan K. orcidid: 0000-0001-9451-2434 surname: Das fullname: Das, Ayan K. organization: Hamdard Institute of Medical Sciences and Research, Jamia Hamdard – sequence: 4 givenname: Zeenat orcidid: 0000-0002-2798-0390 surname: Iqbal fullname: Iqbal, Zeenat email: zeenatiqbal@jamiahamdard.ac.in organization: School of Pharmaceutical Education and Research, Jamia Hamdard – sequence: 5 givenname: Pratima R. orcidid: 0000-0003-1679-2180 surname: Solanki fullname: Solanki, Pratima R. email: partima@mail.jnu.ac.in, partimarsolanki@gmail.com organization: Jawaharlal Nehru University |
BookMark | eNp9UL1OwzAQtlCRaAsDb2CJiSGt7TiNM0YVf1IrMgBr5CQX4Sqxg-0IdeMReEaeBEOZkEA66Ybv7-6boYk2GhA6p2RBCWFLOQyLhMScHKEpJVka8RUTEzQNGI1EliUnaObcjhBKE7KaIls85ctiu83xYLp9DxZXHegGGlybfjBOecDQQe2tccOosZbatKoC63AvPZa6wf4ZlA1yD9or2eHRAZYuQGG8-nh7r1SQdD0erGnG2p-i41Z2Ds5-9hw9Xl89rG-jzf3N3TrfRHUc7o94krKMpgmv4jptM9YwzmIqGJe8agk0NF5xASkRklUpybisq1aINhNAWZO0TTxHFwffkPsygvPlzoxWh8iScZERGuzSwLo8sOrwobPQloNVvbT7kpLyq9IyVFp-Vxq4y1_cWnnpldHeStX9p3hVHez_ti7zojgoPgEicIsF |
CitedBy_id | crossref_primary_10_1016_j_jddst_2022_103140 crossref_primary_10_1080_00914037_2021_2008391 crossref_primary_10_1038_s43586_023_00278_z crossref_primary_10_3390_ma16062249 crossref_primary_10_1021_acsomega_3c02141 crossref_primary_10_1016_j_desal_2023_116638 crossref_primary_10_1002_app_50653 crossref_primary_10_1016_j_mtcomm_2023_107950 crossref_primary_10_56294_sctconf2024873 crossref_primary_10_1016_j_mtcomm_2022_103784 crossref_primary_10_1002_app_51716 crossref_primary_10_1016_j_jddst_2024_106566 crossref_primary_10_61112_jiens_1417524 |
Cites_doi | 10.3390/ijms17111790 10.1088/1468-6996/12/1/013002 10.1016/j.molliq.2017.07.002 10.1088/1757-899X/64/1/012011 10.3390/polym11101550 10.1515/polyeng-2012-0096 10.1016/j.ejbas.2015.06.001 10.1080/21691401.2018.1548475 10.1016/j.ijpharm.2016.12.008 10.1016/j.ijpharm.2019.118480 10.1088/0957-4484/18/7/075605 10.3390/pharmaceutics11100527 10.3109/21691401.2014.924007 10.1016/j.msec.2018.07.036 10.1016/j.msec.2016.12.112 10.18689/mjft-1000101 10.1016/j.matlet.2009.09.043 10.1039/C8BM01640B 10.1016/j.materresbull.2010.12.022 10.1080/09205063.2015.1116885 10.1021/acsapm.9b00179 10.3390/ijms20184395 10.1016/j.jcma.2017.07.012 10.1021/acs.molpharmaceut.6b00039 10.3390/medicina55060294 10.1016/j.msec.2017.04.084 10.17576/jsm-2018-4708-17 10.1016/j.reactfunctpolym.2018.09.001 10.1016/B978-0-08-102198-9.00012-0 10.1016/j.msec.2019.109917 10.1021/acs.molpharmaceut.5b00804 |
ContentType | Journal Article |
Copyright | 2020 Wiley Periodicals LLC. 2021 Wiley Periodicals LLC. |
Copyright_xml | – notice: 2020 Wiley Periodicals LLC. – notice: 2021 Wiley Periodicals LLC. |
DBID | AAYXX CITATION 7SR 8FD JG9 |
DOI | 10.1002/app.50340 |
DatabaseName | CrossRef Engineered Materials Abstracts Technology Research Database Materials Research Database |
DatabaseTitle | CrossRef Materials Research Database Technology Research Database Engineered Materials Abstracts |
DatabaseTitleList | Materials Research Database CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering |
EISSN | 1097-4628 |
EndPage | n/a |
ExternalDocumentID | 10_1002_app_50340 APP50340 |
Genre | article |
GrantInformation_xml | – fundername: Department of Biotechnology, Ministry of science and technology, India |
GroupedDBID | -~X .3N .GA 05W 0R~ 10A 1L6 1OB 1OC 1ZS 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AAHQN AAMNL AANLZ AAONW AAXRX AAYCA AAZKR ABCQN ABCUV ABIJN ABJNI ABPVW ACAHQ ACBEA ACCFJ ACCZN ACGFO ACGFS ACIWK ACNCT ACPOU ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AUFTA AZBYB AZVAB BAFTC BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRSTM DU5 EBS F00 F01 F04 G-S G.N GNP GODZA H.T H.X HBH HGLYW HHY HHZ HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG P2P P2W P2X P4D Q.N Q11 QB0 QRW R.K RNS ROL RWB RWI RX1 RYL SUPJJ UB1 V2E V8K W8V W99 WBKPD WFSAM WH7 WIB WIH WIK WJL WOHZO WQJ WRC WXSBR WYISQ XG1 XPP XV2 ZZTAW ~IA ~KM ~WT AAYXX ADMLS AEYWJ AGHNM AGYGG CITATION 7SR 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY JG9 |
ID | FETCH-LOGICAL-c3340-457291754b3c7f92d24231824a4bf0ed13648e708a2b7094acbf88f98e12d5fd3 |
IEDL.DBID | DR2 |
ISSN | 0021-8995 |
IngestDate | Fri Jul 25 11:56:51 EDT 2025 Tue Jul 01 01:59:39 EDT 2025 Thu Apr 24 22:54:48 EDT 2025 Wed Jan 22 16:58:26 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 18 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3340-457291754b3c7f92d24231824a4bf0ed13648e708a2b7094acbf88f98e12d5fd3 |
Notes | Funding information Department of Biotechnology, Ministry of science and technology, India ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
ORCID | 0000-0001-9451-2434 0000-0002-9869-8077 0000-0002-2798-0390 0000-0002-1129-6578 0000-0003-1679-2180 |
PQID | 2489012317 |
PQPubID | 1006379 |
PageCount | 13 |
ParticipantIDs | proquest_journals_2489012317 crossref_primary_10_1002_app_50340 crossref_citationtrail_10_1002_app_50340 wiley_primary_10_1002_app_50340_APP50340 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | May 10, 2021 |
PublicationDateYYYYMMDD | 2021-05-10 |
PublicationDate_xml | – month: 05 year: 2021 text: May 10, 2021 day: 10 |
PublicationDecade | 2020 |
PublicationPlace | Hoboken, USA |
PublicationPlace_xml | – name: Hoboken, USA – name: Hoboken |
PublicationTitle | Journal of applied polymer science |
PublicationYear | 2021 |
Publisher | John Wiley & Sons, Inc Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc |
References | 2007; 18 2019; 7 2017; 517 2019; 11 2019; 55 2019; 1 2018; 81 2019; 104 2019; 567 2014; 25 2011; 10 2011; 12 2013; 7 2016; 17 2011; 6 2013; 6 2016; 13 2018; 47 2014; 64 2017; 73 2018; 132 2010; 64 2016; 1 2016; 3 2019; 20 2013; 33 2019; 47 2017; 78 2018 2007; 7 2011; 46 2018; 93 2017; 242 2016; 27 2016; 44 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 Si D. Y. (e_1_2_7_7_1) 2007; 7 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 Chaturvedi T. P. (e_1_2_7_36_1) 2013; 7 Jannesari M. (e_1_2_7_16_1) 2011; 6 e_1_2_7_30_1 Kulkarni A. P. (e_1_2_7_31_1) 2013; 6 e_1_2_7_25_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 Elshereksi N. W. (e_1_2_7_33_1) 2014; 25 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_37_1 e_1_2_7_38_1 Sahoo S. (e_1_2_7_26_1) 2011; 10 |
References_xml | – volume: 13 start-page: 1393 year: 2016 publication-title: Mol. Pharmaceutics – volume: 25 start-page: 15 year: 2014 publication-title: J. Phys. Sci – volume: 1 start-page: 1613 year: 2019 publication-title: ACS Appl. Polym. Mater. – volume: 55 start-page: 294 year: 2019 publication-title: Medicina – volume: 7 start-page: 2339 year: 2013 publication-title: J. Clin Diagn Res – start-page: 349 year: 2018 – volume: 27 start-page: 157 year: 2016 publication-title: J. Biomater. Sci. Polym. – volume: 11 start-page: 1550 year: 2019 publication-title: Polymer – volume: 20 start-page: 4395 year: 2019 publication-title: Int. J. Mol. Sci – volume: 47 start-page: 1787 year: 2018 publication-title: Sains Malays – volume: 10 start-page: 273 year: 2011 publication-title: Trop. J. Pharm. Res. – volume: 567 start-page: 118480 year: 2019 publication-title: Int. J. Pharm. – volume: 242 start-page: 382 year: 2017 publication-title: J. Mol. Liq. – volume: 132 start-page: 26 year: 2018 publication-title: React. Funct. Polym. – volume: 44 start-page: 122 year: 2016 publication-title: Artif. Cells Nanomed. Biotechnol. – volume: 104 year: 2019 publication-title: Mater. Sci. Eng. – volume: 6 start-page: 993 year: 2011 publication-title: Int. J. Nanomed. – volume: 6 start-page: 11 year: 2013 publication-title: Int. J. Appl. – volume: 73 start-page: 440 year: 2017 end-page: 446 publication-title: Mater. Sci. Eng – volume: 78 start-page: 324 year: 2017 publication-title: Mater. Sci. Eng – volume: 33 start-page: 453 year: 2013 publication-title: J. Polym. Eng. – volume: 3 start-page: 10 year: 2016 publication-title: Egypt. J. Basic Appl. Sci. – volume: 18 year: 2007 publication-title: Nanotechnology – volume: 64 start-page: 9 year: 2010 publication-title: Mater. Lett. – volume: 46 start-page: 569 year: 2011 publication-title: Mater. Res. Bull. – volume: 12 start-page: 013002 year: 2011 publication-title: Sci. Technol. Adv. Mater. – volume: 7 start-page: 83 year: 2007 publication-title: Asian J. Pharmacodynam. Pharmacokin. – volume: 64 year: 2014 publication-title: IOP Conference Series, Materials Science and Engineering – volume: 517 start-page: 135 year: 2017 publication-title: Int. J. Pharm. – volume: 1 start-page: 1 year: 2016 publication-title: Madridge J. Nano. Tec. Sc..i – volume: 11 start-page: 527 year: 2019 publication-title: Pharmaceutics – volume: 13 start-page: 295 year: 2016 publication-title: Mol. Pharmaceutics – volume: 7 start-page: 1643 year: 2019 publication-title: Biomater. Sci – volume: 17 start-page: 1790 year: 2016 publication-title: Int. J. Mol. Sci. – volume: 81 start-page: 7 year: 2018 publication-title: J. Chin. Med. Assoc. – volume: 47 start-page: 228 year: 2019 publication-title: Artif Cells Nanomed. Biotechno.l – volume: 93 start-page: 145 year: 2018 publication-title: Mater. Sci. Eng. C – ident: e_1_2_7_34_1 doi: 10.3390/ijms17111790 – ident: e_1_2_7_6_1 doi: 10.1088/1468-6996/12/1/013002 – volume: 7 start-page: 83 year: 2007 ident: e_1_2_7_7_1 publication-title: Asian J. Pharmacodynam. Pharmacokin. – ident: e_1_2_7_22_1 doi: 10.1016/j.molliq.2017.07.002 – ident: e_1_2_7_28_1 doi: 10.1088/1757-899X/64/1/012011 – ident: e_1_2_7_20_1 doi: 10.3390/polym11101550 – ident: e_1_2_7_30_1 doi: 10.1515/polyeng-2012-0096 – ident: e_1_2_7_25_1 doi: 10.1016/j.ejbas.2015.06.001 – ident: e_1_2_7_11_1 doi: 10.1080/21691401.2018.1548475 – ident: e_1_2_7_9_1 doi: 10.1016/j.ijpharm.2016.12.008 – ident: e_1_2_7_12_1 doi: 10.1016/j.ijpharm.2019.118480 – ident: e_1_2_7_17_1 doi: 10.1088/0957-4484/18/7/075605 – ident: e_1_2_7_37_1 doi: 10.3390/pharmaceutics11100527 – ident: e_1_2_7_38_1 doi: 10.3109/21691401.2014.924007 – volume: 10 start-page: 273 year: 2011 ident: e_1_2_7_26_1 publication-title: Trop. J. Pharm. Res. – ident: e_1_2_7_5_1 doi: 10.1016/j.msec.2018.07.036 – ident: e_1_2_7_19_1 doi: 10.1016/j.msec.2016.12.112 – ident: e_1_2_7_27_1 doi: 10.18689/mjft-1000101 – volume: 6 start-page: 11 year: 2013 ident: e_1_2_7_31_1 publication-title: Int. J. Appl. – ident: e_1_2_7_24_1 doi: 10.1016/j.matlet.2009.09.043 – ident: e_1_2_7_35_1 doi: 10.1039/C8BM01640B – ident: e_1_2_7_29_1 doi: 10.1016/j.materresbull.2010.12.022 – volume: 7 start-page: 2339 year: 2013 ident: e_1_2_7_36_1 publication-title: J. Clin Diagn Res – ident: e_1_2_7_14_1 doi: 10.1080/09205063.2015.1116885 – ident: e_1_2_7_4_1 doi: 10.1021/acsapm.9b00179 – ident: e_1_2_7_13_1 doi: 10.3390/ijms20184395 – volume: 25 start-page: 15 year: 2014 ident: e_1_2_7_33_1 publication-title: J. Phys. Sci – ident: e_1_2_7_2_1 doi: 10.1016/j.jcma.2017.07.012 – ident: e_1_2_7_15_1 doi: 10.1021/acs.molpharmaceut.6b00039 – ident: e_1_2_7_32_1 doi: 10.3390/medicina55060294 – ident: e_1_2_7_21_1 doi: 10.1016/j.msec.2017.04.084 – volume: 6 start-page: 993 year: 2011 ident: e_1_2_7_16_1 publication-title: Int. J. Nanomed. – ident: e_1_2_7_18_1 doi: 10.17576/jsm-2018-4708-17 – ident: e_1_2_7_23_1 doi: 10.1016/j.reactfunctpolym.2018.09.001 – ident: e_1_2_7_3_1 doi: 10.1016/B978-0-08-102198-9.00012-0 – ident: e_1_2_7_8_1 doi: 10.1016/j.msec.2019.109917 – ident: e_1_2_7_10_1 doi: 10.1021/acs.molpharmaceut.5b00804 |
SSID | ssj0011506 |
Score | 2.4169328 |
Snippet | Bacterial infections have increased dramatically due to microbial biofilm formation resulting in chronic pathological conditions in human subjects. Microbial... |
SourceID | proquest crossref wiley |
SourceType | Aggregation Database Enrichment Source Index Database Publisher |
SubjectTerms | Antibiotics Bacterial diseases biofilm Biofilms drug delivery systems E coli electrospinning Materials science Microorganisms Morphology Nanofibers Penetration resistance Polymers Polymethyl methacrylate Polyvinyl alcohol Sustained release Thermal analysis |
Title | PVA/PMMA polymer blended composite electrospun nanofibers mat and their potential use as an anti‐biofilm product |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fapp.50340 https://www.proquest.com/docview/2489012317 |
Volume | 138 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTuMwELYQXOCwsPxoC6WyEAcuoYnjEFecInYRWlFUscuKA1JkO7aEaEPVpAc48Qg84z7JzjhJ212BtELKIVLGseOZib9xJt8QcsiUDDMdKk_2QuNxZQNPCSW8CCKxyDdM-hoDxf7VycUN_34b3S6R0-ZfmIofYrbhhp7h3tfo4FIV3TlpKJbBivyQY7yOuVoIiK5n1FEIdE6q9I7Ag5gialiFfNadtfx7LZoDzEWY6taZ83Vy14ywSi95OJ6W6lg__0Pe-MFH2CCfavxJk8pgPpMlk2-StQVWwi0yGfxKuoN-P6Hjx-HTyEyoGrqNcor555jkZWhdPacYT3OayxwsVAGOpAB_qcwz6j4_QPMSc5Ggu2lhqCzgEhzl_e-XV3WPpcJHdFwRzm6Tm_NvP88uvLo0g6dDGK_HIwDlgDy4CnVseyxDWAahCpegbt9koBAuTOwLyVQMEaTUygphe8IELItsFu6Q5fwxN18IFdpKrKAkrLAcDAqWSxEG3OqAxzZmokWOGiWluuYtx_IZw7RiXGYpTGPqprFFDmai44qs4y2hdqPptPbXImVc9BBdBjF051T2_g3SZDBwJ7v_L7pHVhlaoqN9bZPlcjI1-4BmStUhK8nX_uWPjjPfP2iI840 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NS8MwGA6iB_Xgt_htEA9e6tokXTPwMsQxPyZDVLxISdIEhrOOrTvoyZ_gb_SX-CZt5xQFEXooNGnSvG-a503fPg9C-0QKmigqPVGj2mPSBJ7kknshRGKhr4nwlQ0UW5fV5g07uwvvJtBR-S9Mzg8x2nCzM8O9r-0EtxvSlU_WUKuDFfqUQcA-ZRW9XUB1NSKPslCnmid4BB5EFWHJK-STyqjq19XoE2KOA1W30jTm0X3ZxzzB5OFwmMlD9fKNvvG_D7GA5goIiuu5zyyiCZ0uodkxYsJl1G_f1ivtVquOe0_d50fdx7Lr9sqxTUG3eV4aFwI6g94wxalIwUklQEkMCBiLNMHuCwRUz2w6EjQ3HGgsBnAJjqzz_vomO1Yt_BH3cs7ZFXTTOLk-bnqFOoOnKPTXYyHgcgAfTFIVmRpJLDKDaIUJsLivk4BWGdeRzwWREQSRQknDualxHZAkNAldRZPpU6rXEObKCCuixA03DHwKVkxOA2ZUwCITEb6ODkorxaqgLrcKGt04J10mMQxj7IZxHe2NivZyvo6fCm2Vpo6LKTuICeM1CzCDCJpzNvv9BnG93XYnG38vuoumm9eti_ji9PJ8E80Q65aOBXYLTWb9od4GcJPJHefDH-gc9hQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS-QwFA6isOjD6nrB624QH3yp0ybpNINPg-7gqiNFVHwQSpImIDvTKTOdB33yJ_gb_SWepO14QUGEPhR60qQ55zTfSU-_g9AOkYKmikpPtKj2mDSBJ7nkXgiRWOhrInxlA8XuWfPokh1fh9dTaL_-F6bkh5hsuFnPcO9r6-B5ahovpKG2DFboUwbx-gxr-tya9OH5hDvKIp1mmd8ReBBUhDWtkE8ak6ZvF6MXhPkap7qFpjOPbuohlvkl__fGhdxT9-_YG7_5DAvoZwVAcbu0mF9oSmeLaO4VLeESGsZX7Ubc7bZxPujd9fUQy57bKcc2Ad1meWlclc8Z5eMMZyIDE5UAJDHgXyyyFLvvD9C8sMlI0N14pLEYwSU4itunh0d5a2uF93FeMs4uo8vO34uDI6-qzeApCuP1WAioHKAHk1RFpkVSi8sgVmEC9O3rNKBNxnXkc0FkBCGkUNJwblpcByQNTUpX0HQ2yPQqwlwZYUsoccMNA4uC9ZLTgBkVsMhEhK-h3VpJiaqIy239jF5SUi6TBKYxcdO4hrYnonnJ1vGR0Gat6aRy2FFCGG9ZeBlE0J1T2ec3SNpx7E7Wvy76B_2IDzvJ6b-zkw00S6xROgrYTTRdDMd6C5BNIX87C34GME_0zA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PVA+%2F+PMMA+polymer+blended+composite+electrospun+nanofibers+mat+and+their+potential+use+as+an+anti%E2%80%90biofilm+product&rft.jtitle=Journal+of+applied+polymer+science&rft.au=Singh%2C+Manvi&rft.au=Chauhan%2C+Deepika&rft.au=Das%2C+Ayan+K.&rft.au=Iqbal%2C+Zeenat&rft.date=2021-05-10&rft.issn=0021-8995&rft.eissn=1097-4628&rft.volume=138&rft.issue=18&rft_id=info:doi/10.1002%2Fapp.50340&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_app_50340 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-8995&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-8995&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-8995&client=summon |